Summary Sterculic acid, a A-9-desaturase inhibitor, administered to rats caused a rise in the stearic:oleic acid ratio of total lipids in peripheral red cells, serum and liver (P <0.001). As a reduction in the stearic:oleic acid ratio has been described in cancer cells, we investigated the effect of sterculic acid on tumour growth. Female F344 rats were injected subcutaneously with two different doses of sterculic acid for 4 weeks prior to, and 4 weeks following, implantation of a nitrosomethylurea-induced mammary tumour. Tumour growth was inhibited equally by the two doses of sterculic acid (P <0.001). A rise in the stearic:oleic acid ratio of tumours was observed in rats treated for only 16 (Segi et al., 1966; Drasar & Irving, 1973) . Monounsaturated, saturated and polyunsaturated fats were found to correlate with breast cancer incidence in a case control study (Miller et al., 1978 al., 1978; Wicha et al., 1979) and also in vivo (Bennett, 1984; Habib et al., 1987) . Stearic acid may inhibit cancer cell growth by increasing the cellular stearic:oleic acid ratio and hence the balance of saturated and unsaturated fatty acids in the tissues. The desaturation of stearic to oleic acid is mediated by A-9-desaturase an important enzyme in the control of tissue fatty acid desaturation. Inhibition of this enzyme, therefore, may inhibit cancer cell growth. Sterculic acid is the most potent A-9-desaturase inhibitor known and is itself a naturally occurring cyclopropene fatty acid derived from a number of plant sources such as Sterculia foetida seed oil. It inhibits the A-9-desaturate system, and de novo synthesis of saturated fatty acids and cholesterol, is unaffected (Zoeller & Wood, 1985) .
Fats have long been linked to cancer promotion. Epidemiological studies have shown that dietary factors, and in particular fat, are linked to several cancers including breast and colon cancer (Segi et al., 1966; Drasar & Irving, 1973) . Monounsaturated, saturated and polyunsaturated fats were found to correlate with breast cancer incidence in a case control study (Miller et al., 1978) . Although such studies do not demonstrate a strong link with any particular type of fat, experimental models of several cancers, including colon and breast cancer, have shown that polyunsaturated fats are more potent promoters of mammary cancer than saturated fats (Carroll & Khor, 1971; Rao & Abraham, 1976) . The relative tissue content of saturated and unsaturated fatty acid may be important in tumour promotion. When individual fatty acids were investigated, linoleate and oleate increased the growth of nitrosomethylureainduced mammary tumour in vivo (Chan et al., 1983) . By contrast, stearic acid inhibited mammary tumour cells in vitro (Doi et al., 1978; Wicha et al., 1979) and also in vivo (Bennett, 1984; Habib et al., 1987) . Stearic acid may inhibit cancer cell growth by increasing the cellular stearic:oleic acid ratio and hence the balance of saturated and unsaturated fatty acids in the tissues. The desaturation of stearic to oleic acid is mediated by A-9-desaturase an important enzyme in the control of tissue fatty acid desaturation. Inhibition of this enzyme, therefore, may inhibit cancer cell growth. Sterculic acid is the most potent A-9-desaturase inhibitor known and is itself a naturally occurring cyclopropene fatty acid derived from a number of plant sources such as Sterculia foetida seed oil. It inhibits the A-9-desaturate system, and de novo synthesis of saturated fatty acids and cholesterol, is unaffected (Zoeller & Wood, 1985) .
The aims of this study were to assess the tolerability of injected sterculic acid in rats and its effect on tissue fatty acid composition and to relate tissue fatty acid composition to inhibition of the growth of a transplanted mammary tumour in rats. 1 mm x 4 mm disc of tumour in the left flank under anaesthesia (Hypnorm; Janssen Pharmaceuticals Ltd, UK). Injections of sterculic acid were continued for 4 weeks, and serial tumour volumes were estimated at 2, 3 and 4 weeks from caliper measurements in two planes using the formula: (max. dimension) x (min. dimension)2 (Attia & Weiss, 1966) . When the first of the animals developed tumours that were 25% of body weight, all were killed using CO2 anaesthesia. Their tumours were dissected out and weighed. Measurements were performed by an assistant who was unaware of the treatment groups.
Materials and methods

Animals
The effects of sterculic acid on the fatty acid composition of this tumour was investigated in a separate investigation. Tumour fragments were implanted subcutaneously in 16 rats which were then allocate to receive either sterculic acid 0.125 ml in 0.5 ml liquid paraffin (n = 8) or liquid paraffin 0.5 ml (n = 8). After 16 days the animals were killed and their tumours and livers were subject to fatty acid analysis as described above.
Lipid extraction At all times the samples were kept under nitrogen gas. All solvents used in the extraction procedure were redistilled and blown with nitrogen. Lipids from the liver and brain were extracted by the Folch method (Folch et al., 1957) . One hundred micrograms of tissue was homogenised in 0.5 ml methanol, and then vortexed in 1.4 ml methanol in chloroform (2:19). It was then revortexed with a further 0.4 ml methanol and centrifuged at 4°C for 10 min at 600 g to remove protein debris. Chloroform (0.7 ml) was added to 2 ml of the supernatant followed by distilled water (0.6 ml). The lower phase was washed three times with 1 ml pure solvent upper phase (CHC13: MeOH:distilled water; 3:48:47) and 0.2 ml methanol was added. Lipids were extracted from the red cells after the method of Slayback et al. (1977) . A dilute red cell suspension (100 gil) was added to 0.9 ml phosphate-buffered saline and I ml acetone and incubated at 90°C for 2 min. The mixture was vortexed with 2 ml of ethylacetate and incubated at 65°C for 20 min, revortexed and incubated for a further 20 min at 65°C. After centrifugation at 200 g for 10 min, the aqueous phase was removed.
Fatty acid extraction
The lipid extract was dried down under nitrogen and free fatty acids were liberated by saponification with I ml 15% methanolic KOH followed by incubation at 65°C for 30 min.
This mixture was diluted with I ml distilled water and acidified with 0.6 ml 4N HCI. Free fatty acids were liberated by adding 2 ml benzene. After centrifugation at 200 g, the bottom phase was discarded. The fatty acids were methylated by the addition of I ml 15% boron trichloride in methanol and then incubation at 95°C for 10 min. After cooling, 2 ml distilled water added to remove unwanted salts and boron trichloride. After centrifugation, the top layer was removed, dried down in an autoloader capsule and redissolved in 3-8 drops of trimethylpentane and sealed under nitrogen.
Gas-liquid chromatography analysis The fatty acid methyl esters (FAME) were analysed by temperature-programmed (160-260°C at 4°C per minute) gas-liquid chromatography (GLC), using a Phillips PU4550 gas chromatograph, with a 2.1 mm x 2 m i. 
Results
No macroscopic evidence of toxicity was observed in the sterculic acid treated animals and there was no evidence of weight loss or debility in the tumour bearing animals treated with sterculic acid compared with controls. In all tissues other than brain in which total lipids were analysed, there was a rise in stearic:oleic acid ratio (P <0.001) brought about by a fall in C18: 1 (oleic acid) and (except in the erythrocytes) a rise in C18:0 (stearic acid). Also, there was a rise in C18:2 (linoleic acid) and a fall in C20:3/4 (eicosatrienoic/arachidonic acid). There was no change in the linolenic acid fraction (C18:3) ( Table I) .
Tumour growth was inhibited in the sterculic acid treated animals as compared with controls (P <0.001 for both doses; Figure 1 ). The final tumour weight of the treated animals were almost one-half of the tumour weights of the control animals 4 weeks after implantation (P <0.01 for both doses; Table II ).
Small differences in the weights of the animals were found between the different groups but their overall growth rate did not differ (Figure 2) . After tumour implantation, the rate of weight gain in the control animals exceeded that of the treated ones. This is accounted for by the larger tumours in the control animals.
After 16 days, tumours of animals treated with sterculic acid demonstrated a significant rise in stearic acid content (P <0.01), a fall in oleic acid content (P <0.05) giving rise to a higher ratio of stearic to oleic acid (P <0.002; Table  III ). The final tumour weights were slightly lower in the sterculic acid group (19.7 ± 3.4 g) compared with controls (32.5 ± 5.9 g) (P < 0.05).
Discussion
Sterculic acid, by subcutaneous injection in non-tumourbearing animals, had major effects on body fat composition. The main changes were seen in liver, plasma and erythrocyte stearic and oleic acid fractions resulting in a rise in the stearic:oleic acid ratio; this effect is expected from inhibition of A-9-desaturase by sterculic acid. In addition, there was a consistent rise in the linoleic acid fraction and fall in the arachidonic/eicosatrienoic acid fraction which can be explained by inhibition of A-6-desaturase activity. This suggests that sterculic acid is not only an inhibitor of A-9-desaturase as has been previously reported in vitro (Jeffcoat & Pollard, 1977) . A rise in linoleic acid and a fall in C20:3/4 fatty acids was also noted in a previous report on the effects of dietary sterculate in rats (Pullarkat et al., 1976 mammary tumour equally over a four-fold dose range.
The experimental evidence from animal work supports the hypothesis that fat is a tumour promoter. Unsaturated fat diets produced a greater yield of 7,12-dimethylbenzanthracene-induced mammary tumours in rats than saturated fats, and when a minimal requirement for unsaturated fats was satisfied, the type of fat required for promotion was immaterial (Carroll & Hopkins, 1979) . However, a diet containing saturated fat with a minimal unsaturated fat content did not promote tumour yield more than a low-fat diet (Braden & Carroll, 1986) . The effects of individual fatty acids have not been investigated as fully as those of lipids, but several studies now support the hypothesis that some fatty acids may actually inhibit cancer. When compared with a control diet, a diet containing 14% stearic acid reduced the yield and prolonged the latency of spontaneously developing mammary carcinomas in strain A/ St mice (Bennett, 1984) . Both injected stearic acid and an iodinated analogue, iodostearic acid, were also shown to inhibit nitrosomethylurea-induced mammary carcinogenesis in rats, and using in vitro clonogenic assay malignant cells were selectively inhibited (Habib et al., 1987) . Stearic acid inhibited the growth of mouse LM cells in vitro (Doi et al., 1978) , and the growth of neoplastic rat mammary epithelial cells was inhibited by stearic acid whereas monounsaturated fatty acids such as oleic acid and polyunsaturated fatty acids promoted growth in vitro (Wicha et al., 1979) . When several endogenous faecal diglycerides were tested for mitogenic potential in colonic adenoma cells in vitro, it was found, with one exception, that all diglycerides stimulated mitogenesis; if the diglyceride contained even a single stearic acid residue, mitogenesis was completely inhibited (Friedman et al., 1989) .
If the stearic:oleic acid ratio were increased by inhibition of A-9-desaturase, tumour growth inhibition would possibly be expected. Sterculic acid, as a potent specific inhibitor of the A-9-desaturase enzyme (Jeffcoat & James, 1984) , is known to increase the stearic:oleic ratio when fed to rats (Reiser & Raju, 1964; Matlock et al., 1985) . Other agents with antineoplastic activity such as retinoids and interferon appear to inhibit A-9-desaturase activity (Alam et al., 1984; Apostolov & Barker, 1981) . Contrary to our findings, however, sterculic acid was found to be a promoter of 2'-acetoaminofluorene-induced liver carcinogenesis in trout (Lee et al., 1968) . Moreover when applied to hepatoma cells in vitro, no inhibition of doubling time was observed (Zoeller & Wood, 1985) . This contrasts with our own findings in which malignant cell growth was inhibited in vitro by sterculic acid (unpublished data).
There are several possible mechanisms by which an increase in the stearic:oleic acid ratio inhibits malignant cell growth. A reduction in the overall cell membrane fatty acid desaturation may reduce membrane fluidity (Boonstra et al., 1982) and small changes in membrane fluidity may cause profound changes in cell membrane receptor function or antigen expression (Sandermann, 1978) . Aylsworth et al. (1987) showed that oleic acid inhibited gap junction intercellular communication whereas saturated fatty acids, including stearic acid, had the opposite effect and suggest that this is the mechanism whereby fats promote tumour growth. Inhibition of protein kinase C activity is suggested as the reason for the effects of fatty acid on gap junctions.
In summary, the result of this investigation supports the hypothesis that a change in C18 fatty acid saturation is important in cancer promotion. This study has shown for the first time that sterculic acid may inhibit tumour growth. The mechanism by which this A-9-desaturase inhibitor has an antineoplastic action is yet to be elucidated. Further studies of sterculic acid and other A-9-desaturase inhibitors are planned.
